Serum Receptor Activator of Nuclear Factor-κ B Ligand, Osteoprotegrin, and Intact Parathyroid Hormone in Hemodialysis and Renal Transplant Patients

MLA

Amir Ghorbanihaghjo, et al. “Serum Receptor Activator of Nuclear Factor-κ B Ligand, Osteoprotegrin, and Intact Parathyroid Hormone in Hemodialysis and Renal Transplant Patients.” Therapeutic Apheresis and Dialysis, vol. 16, Sept. 2012, pp. 600–04. EBSCOhost, https://doi.org/10.1111/j.1744-9987.2012.01097.x.

APA

Amir Ghorbanihaghjo, Javid Safa, Hamidreza Vatankhahan, Hassan Argani, Nadereh Rashtchizadeh, Saeed Mahmoudi Meimand, & Maryam Shahidi. (2012). Serum Receptor Activator of Nuclear Factor-κ B Ligand, Osteoprotegrin, and Intact Parathyroid Hormone in Hemodialysis and Renal Transplant Patients. Therapeutic Apheresis and Dialysis, 16, 600–604. https://doi.org/10.1111/j.1744-9987.2012.01097.x

Chicago

Amir Ghorbanihaghjo, Javid Safa, Hamidreza Vatankhahan, Hassan Argani, Nadereh Rashtchizadeh, Saeed Mahmoudi Meimand, and Maryam Shahidi. 2012. “Serum Receptor Activator of Nuclear Factor-κ B Ligand, Osteoprotegrin, and Intact Parathyroid Hormone in Hemodialysis and Renal Transplant Patients.” Therapeutic Apheresis and Dialysis 16 (September): 600–604. doi:10.1111/j.1744-9987.2012.01097.x.